These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28830848)

  • 21. Newborn screening of maple syrup urine disease and the effect of early diagnosis.
    Chen T; Lu D; Xu F; Ji W; Zhan X; Gao X; Qiu W; Zhang H; Liang L; Gu X; Han L
    Clin Chim Acta; 2023 Aug; 548():117483. PubMed ID: 37421976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age dependence of diffusion-weighted magnetic resonance imaging findings in maple syrup urine disease encephalopathy.
    Sakai M; Inoue Y; Oba H; Ishiguro A; Sekiguchi K; Tsukune Y; Mitomo M; Nakamura H
    J Comput Assist Tomogr; 2005; 29(4):524-7. PubMed ID: 16012312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms.
    Puckett RL; Lorey F; Rinaldo P; Lipson MH; Matern D; Sowa ME; Levine S; Chang R; Wang RY; Abdenur JE
    Mol Genet Metab; 2010 Jun; 100(2):136-42. PubMed ID: 20307994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neonatal maple syrup urine disease case report and literature review.
    Liu Q; Li F; Zhou J; Liu X; Peng J; Gong L
    Medicine (Baltimore); 2022 Dec; 101(50):e32174. PubMed ID: 36550798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.
    Bindu PS; Shehanaz KE; Christopher R; Pal PK; Ravishankar S
    J Child Neurol; 2007 Jul; 22(7):911-3. PubMed ID: 17715290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A classic case with maple syrup urine disease caused by compound heterozygous mutations of BCKDHB gene].
    Song D; Li W; Wei C; Wang W; Lyu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Oct; 35(5):699-702. PubMed ID: 30298499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular genetics of maple syrup urine disease in the Turkish population.
    Gorzelany K; Dursun A; Coşkun T; Kalkanoğlu-Sivri SH; Gökçay GF; Demirkol M; Feyen O; Wendel U
    Turk J Pediatr; 2009; 51(2):97-102. PubMed ID: 19480318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent maple syrup urine disease: two case reports.
    Axler O; Holmquist P
    Pediatrics; 2014 Feb; 133(2):e458-60. PubMed ID: 24394677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational spectrum of maple syrup urine disease in Spain.
    Rodríguez-Pombo P; Navarrete R; Merinero B; Gómez-Puertas P; Ugarte M
    Hum Mutat; 2006 Jul; 27(7):715. PubMed ID: 16786533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Maple syrup urine disease and gene mutations in twin neonates].
    Li T; Wang Y; Li C; Xu WW; Niu FH; Zhang D
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Dec; 18(12):1242-1246. PubMed ID: 27974115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of six novel mutations in five infants with suspected maple syrup urine disease based on blood and urine metabolism screening.
    Yang C; Linpeng S; Cao Y; Wu L
    Gene; 2019 Aug; 710():9-16. PubMed ID: 31112740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetic analysis of MSUD from India reveals mutations causing altered protein truncation affecting the C-termini of E1α and E1β.
    Bashyam MD; Chaudhary AK; Sinha M; Nagarajaram HA; Devi AR; Bashyam L; Reddy EC; Dalal A
    J Cell Biochem; 2012 Oct; 113(10):3122-32. PubMed ID: 22593002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful domino liver transplantation in maple syrup urine disease using a related living donor.
    Feier FH; Miura IK; Fonseca EA; Porta G; Pugliese R; Porta A; Schwartz IV; Margutti AV; Camelo JS; Yamaguchi SN; Taveira AT; Candido H; Benavides M; Danesi V; Guimaraes T; Kondo M; Chapchap P; Neto JS
    Braz J Med Biol Res; 2014 Jun; 47(6):522-6. PubMed ID: 24770567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion-weighted MRI of maple syrup urine disease encephalopathy.
    Cavalleri F; Berardi A; Burlina AB; Ferrari F; Mavilla L
    Neuroradiology; 2002 Jun; 44(6):499-502. PubMed ID: 12070724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis.
    Kilicarslan R; Alkan A; Demirkol D; Toprak H; Sharifov R
    Jpn J Radiol; 2012 Jul; 30(6):522-5. PubMed ID: 22476847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings.
    Parmar H; Sitoh YY; Ho L
    J Comput Assist Tomogr; 2004; 28(1):93-7. PubMed ID: 14716239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maple syrup urine disease encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI.
    Ha JS; Kim TK; Eun BL; Lee HS; Lee KY; Seol HY; Cha SH
    Pediatr Radiol; 2004 Feb; 34(2):163-6. PubMed ID: 14504844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Water apparent diffusion coefficient and T2 changes in the acute stage of maple syrup urine disease: evidence of intramyelinic and vasogenic-interstitial edema.
    Righini A; Ramenghi LA; Parini R; Triulzi F; Mosca F
    J Neuroimaging; 2003 Apr; 13(2):162-5. PubMed ID: 12722501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion magnetic resonance imaging in intermediate form of maple syrup urine disease.
    Sener RN
    J Neuroimaging; 2002 Oct; 12(4):368-70. PubMed ID: 12380485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.
    Jan W; Zimmerman RA; Wang ZJ; Berry GT; Kaplan PB; Kaye EM
    Neuroradiology; 2003 Jun; 45(6):393-9. PubMed ID: 12736767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.